Ligand · V0G
V0G · N-(3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)-4-{[4-(dimethylamino) butanoyl]amino}benzamide
V0G, N-(3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)-4-{[4-(dimethylamino) butanoyl]amino}benzamide (C31 H30 Cl N7 O2, 568.1 g/mol), in the MolNFT structures on GenesisL1: bound in 3 records (2 PDB entries). Every binding…
- Component
- V0G
- Formula
- C31 H30 Cl N7 O2
- Class
- ligand
- Structures
- 3
- PDB entries
- 2
Binding sites
V0G in 3 structures; the first of them:
- 6XD3 · Structure of the human CAK in complex with THZ1 · V0G J401 · binds LEU18, VAL26, ALA39, ILE75, PHE91, PHE93, MET94, GLU95 and 6 more
- 8ORM · Cryo-EM structure of CAK-THZ1 · V0G J401 · binds LEU18, GLY19, GLU20, GLY21, VAL26, ALA39, LYS41, PHE91 and 10 more
- 6XD3 · Structure of the human cak in complex with THZ1 · V0G J401 · binds LEU18, VAL26, ALA39, ILE75, PHE91, PHE93, MET94, GLU95 and 6 more
Residues it binds most
LEU 3, PHE 3, ASP 3, GLU 3, ALA 3, ASN 3, CYS 3, MET 3, PRO 3, THR 3 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.